Cas:55365-10-1 imidazo[1,2-a]pyridine-3-carboxylic acid methyl ester manufacturer & supplier

Chemical Name:imidazo[1,2-a]pyridine-3-carboxylic acid methyl ester

CAS.NO:55365-10-1

Synonyms:3-Methoxycarbonyl-imidazo<1.2-a>pyridin;Imidazo[1,2-a]pyridine-3-carboxylic acid methyl ester

Molecular Formula:C₉H₈N₂O₂

Molecular Weight:176.17200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:43.60000

Exact Mass:176.05900

LogP:1.12090

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-Methoxycarbonyl-imidazo&lt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Imidazo[1,2-a]pyridine-3-carboxylic acid methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1.2-a&gt Use and application,Imidazo[1,2-a]pyridine-3-carboxylic acid methyl ester technical grade,usp/ep/jp grade.

Related News: “We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab,” Sandrock said. “A better understanding of the facts is good for everyone involved to assure confidence in both the therapy and the process by which it was approved as we prioritize the issues that affect patients.” 2-(4-chlorophenyl)-N,N-dimethyl-N-(naphthalen-1-ylmethyl)-2-oxoethan-1-aminium bromide manufacturers The Japanese drugmaker is injecting $126 million into its Thousand Oaks facility to boost manufacturing and support new product lines, Pacific Coast Business Times first reported. Takeda was joined by the city’s mayor, Claudia Bill-de la Peña, for a groundbreaking event on Thursday, July 22. 4-Chloro-N-(4-diethylamino-1-methyl-butyl)-2-nitro-thiobenzamide; hydrochloride suppliers “We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab,” Sandrock said. “A better understanding of the facts is good for everyone involved to assure confidence in both the therapy and the process by which it was approved as we prioritize the issues that affect patients.” benzyl (S)-2-(((10S,13S)-13-((R)-1-(tert-butoxy)ethyl)-2,2-dimethyl-4,11,14-trioxo-3,15-dioxa-5,12-diazaoctadecan-10-yl)carbamoyl)pyrrolidine-1-carboxylate vendor & factory These companies need cost-effective, seamless ways to move small molecule compounds from early-phase to commercial according to global quality and regulatory standards, and these expanded facilities at our Nansha site are designed to help them to do so.”,Aduhelm was approved by the Food and Drug Administration on June 7. The drug, scientifically known as aducanumab, offers new hope to friends and families of patients living with the disease and is expected to generate billions of dollars in revenue for the company.